Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13698774 | 0.86 | TRPA1 (0.40) | TAAR1PTGS1PTGS2 | |
| SCHEMBL13540959 | 0.81 | TAAR1 (0.60) | TAAR1 | |
| SCHEMBL2622769 | 0.80 | ALDH1A1 (0.40) | ESR1ESR2PTGS1PTGS2 | |
| SCHEMBL7852920 | 0.78 | TAAR1 (0.56) | TAAR1 | |
| SCHEMBL13862873 | 0.76 | DAO (0.45) | ESR1ESR2SLC6A2SLC6A4PTGS1 | |
| SCHEMBL16385035 | 0.76 | SLC6A4 (0.40) | TAAR1SLC6A2SLC6A4PTGS1PTGS2 | |
| SCHEMBL19735194 | 0.74 | CYP3A4 (0.44) | ESR1ESR2 | |
| SCHEMBL13545542 | 0.74 | TSHR (0.46) | ESR1ESR2SLC6A2PTGS1PTGS2 | |
| SCHEMBL9073026 | 0.74 | CYP3A4 (0.46) | SLC6A4 | |
| SCHEMBL12167672 | 0.74 | CYP3A4 (0.46) | SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077126-A1 | Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition, Top Coat Composition And Pattern Formation Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077126-A1 | Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition, Top Coat Composition And Pattern Formation Method | FRG1, AFF2, FBXL19 | TAAR1 1676/4885ESR1 821/4885ESR2 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.